|Articles|February 17, 2014
- Applied Clinical Trials-02-01-2014
- Volume 23
- Issue 2
Applied Clinical Trials Digital Edition - February/March 2014
CRO/Sponsor: Integrating Managed Access Programs: Global Considerations Trial Design: How to Improve Clinical Research in Children Also in this issue: Global Experience with Informed Consent Central Statistical Monitoring Sponsor/CRO Interaction
Advertisement
Articles in this issue
over 12 years ago
How to Improve Clinical Research in Childrenover 12 years ago
Integrating Managed Access Programs: Global Considerationsover 12 years ago
Fine-Tuning CRO/Sponsor Interactionover 12 years ago
BRIC Expenditures Increasing at a Much Faster Pace than USover 12 years ago
New Horizons in Research Funding for EUover 12 years ago
FDA, Sponsors Continue Quest for More Efficient Trialsover 12 years ago
ACT Coverover 12 years ago
How to Improve the Quality of Research Reportingover 12 years ago
EMA Guidance Points to Central Statistical MonitoringAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Validity, Reliability, and Regulatory Considerations for Consumer Devices in Clinical Research Data Collection
2
ACT Brief: Real-Time Review Ecosystem Approach, AI Infrastructure Before Tools, and FDA Peptide Compounding Access
3
ACT Brief: ESG as Commercial Selection Factor, Real-Time Monitoring Scale Readiness, and FDA Cancer Trial Eligibility Expansion
4
FDA Finalizes Three Guidances to Broaden Cancer Clinical Trial Eligibility
5